Clin2
NCT05901571Possibly a fitNot yet recruiting

Acupuncture plus escitalopram for major depression

Depressive Disorder, Major

Treatments studied

Part of Mental health clinical trials.

This study tests whether adding acupuncture to escitalopram (an antidepressant) helps people with major depression feel better. It will also compare how the treatment is tolerated and whether depressive symptoms improve.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
216 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have a diagnosis of major depression confirmed by DSM-5 criteria.
  • Your depression score is high enough (HDRS-17 score of 17 or more).
  • You can read and understand Mandarin Chinese, and you agree to follow the study plan and give written consent.
  • You have not had acupuncture in the last year.
  • You are able and willing to receive acupuncture (including getting needle treatments).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07552246Recruiting· Phase 4
Acupuncture vs medication for depression and anxiety

This study compares acupuncture with standard medication for reducing depression, anxiety, and related sleep problems. It aims to see if acupuncture is a helpful alternative for people in China who are struggling with these conditions.

Kunshan, Jiangsu
NCT07003763Recruiting
Electroacupuncture for depression in cancer patients

This trial tests whether electroacupuncture can help treat depression caused by cancer or its treatments. It may be a safe option for people who have not tried acupuncture before and are not currently receiving active cancer treatments.

Shanghai
NCT05480150Recruiting
Study of brain and mood in people with depression or bipolar disorder

This study is following and assessing people with major depression or bipolar disorder to better understand the condition and how the brain relates to symptoms. It may help researchers develop more targeted support by comparing brain and health information over time.

Hangzhou, Zhejiang
NCT06828887Recruiting· Phase 2
Testing LV232 capsules for major depression

This trial tests a new medicine called LV232 for people with moderate to severe depression. Researchers want to find the best dose and check if it works safely.

Shanghai
NCT07611487Not yet recruiting
Brain imaging study of acupuncture for depression

This research examines how acupuncture may help treat depression by looking at brain activity with MRI scans. You'll receive acupuncture treatment while researchers track how your brain responds and measure changes in your mood.

NCT07390981Not yet recruiting
Acupuncture to help lower antidepressant dose in depression

This trial tests whether adding intradermal acupuncture (tiny needles left under the skin for a few days) can help people with major depression safely reduce their dose of SSRI antidepressants. It may offer a way to taper medication with fewer withdrawal symptoms.

Hear when a new Depressive Disorder, Major trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.